Press release
Melanocyte Stimulating Hormone Receptor - Pipeline Review : Share, Growth, Trends and Forecast 2017 - 2022
Market Research Hub
Request For Free Sample @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=843926
The report provides comprehensive information on the Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) targeted therapeutics development and features dormant and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note:
*Certain sections in the report may be removed or altered based on the availability and relevance of data.
*Updated report will be delivered in 48 hours of order confirmation.
Scope
- The report provides a snapshot of the global therapeutic landscape for Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R)
- The report reviews Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) targeted therapeutics and enlists all their major and minor projects
- The report assesses Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) targeted therapeutics
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) Overview 6
Therapeutics Development 7
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Products under Development by Stage of Development 7
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Products under Development by Therapy Area 8
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Products under Development by Indication 9
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Products under Development by Companies 12
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Companies Involved in Therapeutics Development 21
Clinuvel Pharmaceuticals Limited 21
Mallinckrodt Plc 22
Palatin Technologies, Inc. 23
Continue….
Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=843926
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read More Related News: https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Melanocyte Stimulating Hormone Receptor - Pipeline Review : Share, Growth, Trends and Forecast 2017 - 2022 here
News-ID: 587786 • Views: …
More Releases from Medical Industry Research Reports-[MRH]
Global Ophthalmic Diagnostic Devices Sales Market Report : Share, Growth, Size, …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Ophthalmic Diagnostic Devices Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions.
Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324423
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million…
United States Negative Pressure Wound Therapy (NPWT) Market Projections & Upcomi …
This report on the United States negative pressure wound therapy (NPWT) market is filled with necessary details and facts which provide deep insight into this sector. Further, extensive interviews are conducted with chief opinion leaders (KOLs), physicians and industry experts to authenticate the market size, company share as well as distribution share data and analysis. The report titled “United States Negative Pressure Wound Therapy (NPWT) Market Outlook to 2024”, has been…
Global Intraoperative Ultrasound Market, Growth, Analysis, Production, Forecasts …
To Understand the medical equipments Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Global Intraoperative Ultrasound Market Reports September, 2017” to its vast database. This study offers data about the prime regions operating in the medical equipments sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until…
Global RFID Medical Inventory Management Systems Market Research Report Share, G …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global RFID Medical Inventory Management Systems Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions.
Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1313969
Geographically, this report is segmented into several key Regions, with production,…
More Releases for Receptor
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Market: Competitive Dyna …
Global Info Research offers a latest published report on Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in…
DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologo …
DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2020 report by comprehensive insights of present scenario and growth prospects across DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action,…
TRAIL Receptor 1 & Receptor 2 Agonist Pipeline Analysis 2020 Along with Research …
TRAIL Receptor 1 & Receptor 2 Agonist -Pipeline Insight, 2020: The report presents an in-depth assessment of TRAIL Receptor 1 & Receptor 2 Agonist including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for TRAIL Receptor 1 & Receptor 2 Agonist investments from 2020 till 2030
Major Key Players:AbbVie,…
Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Recept …
Market Research Hub (MRH) has added a new report titled “Calcitonin Gene Related Peptide Type 1 Receptor, Pharmaceutical Pipeline Research Report” to its vast data repository. Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1…
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Rece …
"Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Global Markets Directs, Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016, provides in depth analysis on Transient Receptor Potential Cation…
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Recepto …
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2016, provides in depth analysis on Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) targeted pipeline therapeutics.
The report provides comprehensive information on the Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1), targeted therapeutics, complete with analysis by…
